Overgrowth syndromes: is dysfunctional PI3-kinase signalling a unifying mechanism?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Human Genetics

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.ejhg.5201026PMID 12939652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 私の論文から Haploinsufficiency of NSD1 causes Sotos syndrome

  2003cited by this paper
• Germline mutation of the tumour suppressor PTEN in Proteus syndrome

  2002cited by this paper
• Insulin and TNF alpha induce expression of the forkhead transcription factor gene Foxc2 in 3T3-L1 adipocytes via PI3K and ERK 1/2-dependent pathways.

  2002cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

  2002cited by this paper
• TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

  2002cited by this paper
• The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.

  2002cited by this paper
• Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling

  2002cited by this paper
• Insulin‐like growth factor binding protein 2 (IGFBP‐2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF‐I excess on adrenocortical cells in vivo

  2002cited by this paper
• A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.

  2002cited by this paper
• Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase B

  2002cited by this paper
• Haploinsufficiency of NSD1 causes Sotos syndrome

  2002cited by this paper
• Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice

  2002cited by this paper
• Akt regulates growth by directly phosphorylating Tsc2

  2002cited by this paper
• Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo

  2001cited by this paper
• Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease

  2001cited by this paper
• Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.

  2001cited by this paper
• Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease

  2001cited by this paper
• PTEN mutations are uncommon in Proteus syndrome.

  2001cited by this paper
• PTEN mutations and proteus syndrome.

  2001cited by this paper
• TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

  2001cited by this paper
• Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes.

  2001cited by this paper
• Mechanisms of size control.

  2001cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis.

  2000cited by this paper
• Do growth and cell division rates determine cell size in multicellular organisms?

  2000cited by this paper
• Genetic control of cell size.

  2000cited by this paper
• A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.

  1999cited by this paper
• PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development.

  1999cited by this paper
• Signaling by distinct classes of phosphoinositide 3-kinases.

  1999cited by this paper
• Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.

  1999cited by this paper
• Elattoproteus syndrome: delineation of an inverse form of Proteus syndrome.

  1999cited by this paper
• Drosophila S6 kinase: a regulator of cell size.

  1999cited by this paper
• Ribosomal S6 kinase signaling and the control of translation.

  1999cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.

  1998cited by this paper
• The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate*

  1998cited by this paper
• Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

  1998cited by this paper
• The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

  1998cited by this paper
• Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.

  1997cited by this paper
• Tuberous sclerosis associated with histologically confirmed ocular and cerebral tumors.

  1995cited by this paper
• Growth hormone (GH), insulin-like growth factors (IGFs), and IGF-binding protein-3 (IGFBP-3) in a child with Proteus syndrome.

  1994cited by this paper
• Cowden syndrome and lhermitte‐duclos disease

  1992cited by this paper
• Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin.

  1987cited by this paper
• Amino acid sequence of the mRNA cap-binding protein from human tissues.

  1987cited by this paper
• The proteus syndrome

  1983cited by this paper
• A newly recognized hamartomatous syndrome.

  1979cited by this paper
• A newly recognized hamartomatous syndrome.

  1979cited by this paper

• Glutaminolysis and the Control of Neural Progenitors in Neocortical Development and Evolution

  2022cites this paper
• Conditional Pten knockout in parvalbumin- or somatostatin-positive neurons sufficiently leads to autism-related behavioral phenotypes

  2020cites this paper
• Clinical Profile of Overgrowth Syndromes Consistent with PROS (PIK3CA-Related Overgrowth Syndromes)—A Case Series

  2020cites this paper
• Tuberous sclerosis with segmental overgrowth.

  2020cites this paper
• Vascular Overgrowth

  2019cites this paper
• Overgrowth Syndromes Associated with Slow-Flow Vascular Malformations Congenital Lipomatous Asymmetric Overgrowth

  2018cites this paper
• Systemic signalling and local effectors in developmental stability, body symmetry, and size

  2018cites this paper
• Fibroblasts derived from patients with opsismodysplasia display SHIP2‐specific cell migration and adhesion defects

  2017cites this paper
• Chapter 2 Vascular Overgrowth

  2017cites this paper
• PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib

  2016cites this paper
• Brain overgrowth in disorders of RTK-PI3K-AKT signaling: a mosaic of malformations.

  2015cites this paper
• Differential Diagnoses of Overgrowth Syndromes: The Most Important Clinical and Radiological Disease Manifestations

  2014cites this paper
• Intestinal bleeding from arteriovenous malformations of the small bowel in a patient with Cowden syndrome: report of a case

  2013cites this paper
• Ed. Washington DC: American Psychiatric Association. Ashwal S, Michelson D, Plawner L. 2009. Practice Parameter: Evaluation of the child with microcephaly. Neurology. 73:887-96. Ayatollahi SMT, Shayan Z. Head circumference standards for school children

  2012cites this paper
• The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly

  2009cites this paper
• Excision of a large abdominal wall lipoma improved bowel passage in a Proteus syndrome patient.

  2009cites this paper
• Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo

  2004cites this paper